Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
March, 2026
March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
John Abraham: Understanding rFVIIa Through the Cell Based Model of Coagulation
John Abraham/LinkedIn
Mar 18, 2026, 15:40

John Abraham: Understanding rFVIIa Through the Cell Based Model of Coagulation

John Abraham, Assistant Professor at Christian Medical College and Hospital, shared a post on LinkedIn:

“Recently co-authored a chapter on clotting disorders in pregnancy.

While writing it, I went back and deep dived into the cell-based model of coagulation — and somewhere along the way, something just clicked.

Revisiting the model :

  • Initiation gives only a small thrombin signal
  • Amplification prepares the platelet surface
  • Propagation is where the real action happens – thrombin burst

The system is designed so that effective clotting is platelet-surface driven

The moment of clarity: rFVIIa (NovoSeven)

While going through this, the mechanism suddenly made complete sense:

  • If clot formation depends on platelet-surface thrombin generation
  • Then you don’t necessarily need the entire intrinsic pathway

rFVIIa at pharmacologic doses:

  • Acts directly on activated platelets
  • Generates FXa independent of TF
  • Bypasses FVIII / FIX

Result: restoration of the thrombin burst exactly where it matters

Why this felt important:

  • Explains its efficacy in hemophilia with inhibitors
  • Connects physiology – pharmacology in a very direct way
  • Turns what feels like a ‘black box drug’ into a predictable mechanism

A good reminder — sometimes revisiting what you already know, but in depth, can change how clearly you see it.”

John Abraham: Understanding rFVIIa Through the Cell Based Model of Coagulation

Stay updated with Hemostasis Today.

bleeding disorders Health Hematology Hemophilia Hemostasis Hemostasis News Hemostasis Today John Abraham Medicine RfviiA thrombosis
NewsFeed